Anstey KJ, Peters R. Dementia prevention. NHMRC partnership centre for dealing with cognitive and related functional decline in older people. Sydney: National Health and Medical Research Council (NHMRC); 2019. https://cdpc.sydney.edu.au/research/care-service-pathways/
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012;(3):CD007176. https://www.ncbi.nlm.nih.gov/pubmed/22419320
Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev 2016;4:CD009002. https://www.ncbi.nlm.nih.gov/pubmed/27063583
Farina N, Llewellyn D, Isaac M, Tabet N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment. Cochrane Database Syst Rev 2017;4:CD002854. https://www.ncbi.nlm.nih.gov/pubmed/28418065
Fink HA, Linskens EJ, MacDonald R, Silverman PC, McCarten JR, Talley KMC, et al. Benefits and harms of prescription drugs and supplements for treatment of clinical Alzheimer-type dementia. Ann Intern Med 2020;172(10):656–68. https://www.ncbi.nlm.nih.gov/pubmed/32340037
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396(10248):413–46. https://www.ncbi.nlm.nih.gov/pubmed/32738937
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet 2017;390(10113):2673–734. https://www.ncbi.nlm.nih.gov/pubmed/28735855
National Institute for Health and Care Excellence (NICE). Dementia: assessment, management and support for people living with dementia and their carers (NG97). London: NICE; 2018. https://www.nice.org.uk/guidance/ng97
NSW Therapeutic Advisory Group (TAG). Deprescribing guide for antipsychotics for treatment of behavioural and psychological symptoms of dementia. Sydney: NSW TAG; 2018. https://www.nswtag.org.au/deprescribing-tools/
O’Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I, et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol 2017;31(2):147–68. https://www.ncbi.nlm.nih.gov/pubmed/28103749
Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C. Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel. Intern Med J 2016;46(10):1189–97. https://www.ncbi.nlm.nih.gov/pubmed/27527376
Volkert D, Chourdakis M, Faxen-Irving G, Fruhwald T, Landi F, Suominen MH, et al. ESPEN guidelines on nutrition in dementia. Clin Nutr 2015;34(6):1052–73. https://www.ncbi.nlm.nih.gov/pubmed/26522922
